Who is eligible for Brainsway's TMS therapy?Read More
This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Has BrainsWay’s Deep TMS therapy been tested?
BrainsWay Deep TMS therapy has been tested in over 60 clinical studies, for various clinical indications, in leading institutions worldwide.
The FDA has cleared this BrainsWay Deep TMS therapy for treatment resistant depression and it is currently available in the U.S., Europe, and South America.
BrainsWay is also indicated by the FDA as an intended adjunct treatment for adult patients suffering from Obsessive Compulsive Disorder (OCD)/FDA De Novo.